Characterization and Clinical Utility of

BRAFV600 mutations cell-free DNA melanoma

Journal

Cancers
ISSN: 2072-6694
Titre abrégé: Cancers (Basel)
Pays: Switzerland
ID NLM: 101526829

Informations de publication

Date de publication:
17 Jul 2021
Historique:
received: 19 05 2021
revised: 09 07 2021
accepted: 14 07 2021
entrez: 24 7 2021
pubmed: 25 7 2021
medline: 25 7 2021
Statut: epublish

Résumé

Tissue-based tests for

Identifiants

pubmed: 34298804
pii: cancers13143591
doi: 10.3390/cancers13143591
pmc: PMC8305047
pii:
doi:

Types de publication

Journal Article

Langues

eng

Subventions

Organisme : F. Hoffmann-La Roche Ltd; Genentech, Inc., a member of the Roche Group; and Biocartis Group NV
ID : No grant number

Références

Ann Oncol. 2020 Nov;31(11):1435-1448
pubmed: 32763453
Melanoma Manag. 2016 Mar;3(1):33-45
pubmed: 30190871
Melanoma Res. 2018 Apr;28(2):96-104
pubmed: 29232304
Mod Pathol. 2019 Mar;32(3):330-337
pubmed: 30315274
Exp Dermatol. 2016 Oct;25(10):783-8
pubmed: 27194447
Mol Cancer Ther. 2016 Jun;15(6):1397-404
pubmed: 27207774
Lancet Oncol. 2016 Sep;17(9):1248-60
pubmed: 27480103
Ann Oncol. 2021 Jul;32(7):854-865
pubmed: 33771664
Proteome Sci. 2011 Jun 08;9(1):29
pubmed: 21651755
J Clin Oncol. 2009 Dec 20;27(36):6199-206
pubmed: 19917835
Curr Oncol Rep. 2019 Nov 25;21(12):106
pubmed: 31768772
Melanoma Res. 2019 Aug;29(4):358-364
pubmed: 30896556
Ann Transl Med. 2015 Nov;3(20):309
pubmed: 26697469
Oncotarget. 2017 Jan 31;8(5):8069-8082
pubmed: 28039443
Nature. 2002 Jun 27;417(6892):949-54
pubmed: 12068308
Front Mol Biosci. 2020 Jun 30;7:113
pubmed: 32695793
Cancer Lett. 2017 Sep 28;404:62-69
pubmed: 28687355
Oncotarget. 2015 Sep 29;6(29):26886-94
pubmed: 26330075
Tumori. 2020 Feb 6;:300891619900928
pubmed: 32026754
J Transl Med. 2016 Apr 19;14:95
pubmed: 27095081
Asia Pac J Clin Oncol. 2016 Dec;12(4):403-408
pubmed: 27488807
Oncotarget. 2018 Nov 16;9(90):36238-36249
pubmed: 30546839
Mod Pathol. 2018 Jan;31(1):24-38
pubmed: 29148538
PLoS One. 2016 Apr 25;11(4):e0153576
pubmed: 27111917
Sci Rep. 2021 Apr 27;11(1):9043
pubmed: 33907234
Genet Test Mol Biomarkers. 2019 Apr;23(4):241-245
pubmed: 30676087
Lancet Oncol. 2017 Apr;18(4):464-472
pubmed: 28268064
Melanoma Res. 2017 Dec;27(6):527-535
pubmed: 28858076
N Engl J Med. 2014 Nov 13;371(20):1867-76
pubmed: 25265494

Auteurs

Piotr Rutkowski (P)

Maria Sklodowska-Curie National Research Institute of Oncology, 00-001 Warsaw, Poland.

Patrick Pauwels (P)

Department of Pathology, Antwerp University Hospital, 2650 Edegem, Belgium.
Centre for Oncological Research (CORE), Antwerp University, 2610 Wilrijk, Belgium.

Joseph Kerger (J)

Institut Jules Bordet, Université Libre de Bruxelles (ULB), 1000 Brussels, Belgium.

Bart Jacobs (B)

Biocartis, 2800 Mechelen, Belgium.

Geert Maertens (G)

Biocartis, 2800 Mechelen, Belgium.

Valerie Gadeyne (V)

F. Hoffmann-La Roche, 4070 Basel, Switzerland.

Anne Thielemans (A)

F. Hoffmann-La Roche, 4070 Basel, Switzerland.

Katrien de Backer (K)

F. Hoffmann-La Roche, 4070 Basel, Switzerland.

Bart Neyns (B)

Department of Medical Oncology, Vrije Universiteit Brussel (VUB), Universitair Ziekenhuis Brussel (UZ Brussel), 1090 Brussels, Belgium.

Classifications MeSH